Insight into Recent Methods for Synthesizing Andrographolide Derivatives and their Potential Pharmaceutical Effects

Area of Science:

• Medicinal Chemistry
• Pharmacology
• Drug Discovery

Background:

• Andrographolide (ANDR), a natural compound, faces limitations in bioavailability and solubility.
• Medicinal chemistry efforts focus on developing effective ANDR derivatives to overcome these limitations.
• This review synthesizes recent advancements in ANDR derivatives, including their pharmacology, SAR, and patent landscape.

Purpose of the Study:

• To provide a comprehensive overview of Andrographolide (ANDR) derivatives.
• To highlight chemical modifications that enhance ANDR's bioavailability and pharmacological activity.
• To analyze structure-activity relationships (SAR) and the patent landscape of ANDR analogs.

Main Methods:

• Systematic review of recent literature and patents.
• Emphasis on chemical strategies for modifying the ANDR scaffold.
• Summary of biological evaluation results from preclinical studies.

Main Results:

• Various ANDR derivatives with modifications at C-3, C-12, C-14, and C-19 positions show significant potency gains.
• Recent analogs exhibit superior efficacy compared to native ANDR in cell-based and in vivo studies.
• Esterification and hybridization strategies yield analogs with enhanced antifibrotic, antitumor, and antibacterial biofilm inhibition effects, alongside improved bioavailability and reduced cytotoxicity.

Conclusions:

• Strategic modifications of the ANDR scaffold can enhance potency, selectivity, and pharmacokinetic properties.
• Despite promising preclinical results, challenges like solubility, toxicity assessment, and limited pharmacokinetic data impede clinical advancement.
• This review offers a roadmap for developing potent and safe ANDR analogs for translational research targeting major human diseases.